Cargando…
Dexamethasone/voriconazole: Invasive aspergillosis following off-label use; lack of efficacy: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023712/ http://dx.doi.org/10.1007/s40278-022-13722-1 |
Ejemplares similares
-
Azithromycin/dexamethasone/voriconazole: Pulmonary aspergillosis following off-label use, and lack of efficacy: case report
Publicado: (2021) -
Convalescent-anti-SARS-CoV-2-plasma/dexamethasone/voriconazole: Invasive pulmonary aspergillosis, off label use and lack of efficacy: case report
Publicado: (2021) -
Dexamethasone: Invasive pulmonary aspergillosis following off-label use: case report
Publicado: (2021) -
Dexamethasone: Lack of efficacy following off-label use: case report
Publicado: (2022) -
Voriconazole: Lack of efficacy during treatment of invasive pulmonary aspergillosis: 2 case reports
Publicado: (2021)